Results 1 to 10 of about 988,621 (236)

Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Chronic Rhinosinusitis with Nasal Polyps [PDF]

open access: yesTurkish Archives of Otorhinolaryngology
Objective: Inflammatory processes play a role in the etiopathogenesis of chronic rhinosinusitis. Many gene polymorphisms have been associated with inflammation.
Mehmet Emre Sivrice   +4 more
doaj   +2 more sources

AKTIVIITAS ANTIOKSIDAN ANTIHIPERLIPIDEMIA DAN ANTIHIPERTENSI DARI EKSTRAK ETANOL DAUN KEDABU (Sonneratia ovata. Backer)

open access: yesJIIS: Jurnal Ilmiah Ibnu Sina
            Kedabu (Sonneratia ovata. Backer) merupakan salah satu jenis mangrove dari genus Sonneratia dengan kandungan tinggi flavonoid yang berpotensi sebagai antioksidan. Kandungan flavonoid dalam tumbuhan kedabu meliputi sonnerphenolic, vanillin, (-
Danang Raharjo   +2 more
doaj   +1 more source

Mechanisms of the antihypertensive effects of Nigella sativa oil in L-NAME-induced hypertensive rats

open access: yesClinics, 2015
OBJECTIVES: This study was conducted to determine whether the blood pressure-lowering effect of Nigella sativa might be mediated by its effects on nitric oxide, angiotensin-converting enzyme, heme oxygenase and oxidative stress markers.
Kamsiah Jaarin   +8 more
doaj   +1 more source

The use of angiotensin-converting enzyme inhibitors in general medicine

open access: yesSouth African Family Practice, 2012
Angiotensin-converting enzyme (ACE) inhibitors are a class of drugs commonly used in the management of hypertension, congestive heart failure, cerebrovascular disease, stable coronary heart disease and diabetes-associated nephropathy.
M.L.I. Mashitisho
doaj   +1 more source

ANGIOTENSIN CONVERTING ENZYME INHIBITORS, ANGIOTENSIN II RECEPTOR ANTAGONISTS AND RENOPROTECTION

open access: yesTurkish Journal of Nephrology, 2019
-
Alpaslan ERSOY, Kamil DİLEK
doaj  

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION

open access: yesРациональная фармакотерапия в кардиологии, 2015
Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy.
I. V. Szirov, E. V. Malichenko
doaj   +1 more source

Lung Diseases and Angiotensin-Converting Enzyme

open access: yesEurasian Journal of Medicine, 2019
-
Mecit Süerdem
doaj  

The Effect of Eight-Week Aerobic Training on Serum Angiotensin Converting Enzyme and Lipid Profile in Inactive Overweight Women [PDF]

open access: yesJournal of Advanced Biomedical Sciences, 2019
Background & Objective: At present, the prevalence of hypertension is growing and one of the contributing factors in the occurrence and development of hypertension and atherosclerosis is impaired renin–angiotensin system which in this system endothelium ...
nahid Bijeh   +4 more
doaj  

Research Progress on the Mechanism of Action of Food-Derived ACE-Inhibitory Peptides

open access: yesLife
Hypertension is a major pathogenic contributor to cardiovascular diseases, primarily mediated through activation of the angiotensin-converting enzyme (ACE) system.
Ting Li   +6 more
doaj   +1 more source

Comparison of Efficacy of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs) in Delaying Diabetic Nephropathy

open access: yesPakistan Armed Forces Medical Journal
Objective: To compare the effect of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers on renal damage in terms of change in mean albumin-to-creatinine ratio. Study Design: Cross-sectional study. Study Place and Duration: PNS
Fraz Tahir   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy